Impact of Fas/FasL in Chemotherapy Response in Epithelial Ovarian Carcinoma

计划入组 28 人 · 首次发布于 2014 年 11 月 21 日

Preventing FAS/ARND in Russian Children

计划入组 767 人 · 首次发布于 2013 年 10 月 11 日

Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma

计划入组 68 人 · 首次发布于 2014 年 10 月 21 日

FAS-115

FAS-3075

FAS-20013

Fascinate Therapeutics, Inc.

United States

PharmacoPhotonics, Inc.

United States

WHELAN,RICHARD,

Ireland

FAS Investigates Teva and Grotex for Alleged Unfair Competition Over Generic Apixaban Launch

STIMULATE-ICP: Largest Long COVID Trial Finds Specialist Care Reduces Fatigue, but Multi-Organ MRI Adds No Benefit

Pharming Group Initiates Phase II Trial of Leniolisib for Primary Immunodeficiencies